zanolimumab expected trade name human monoclonal antibody immunosuppressive developed goal treatment rheumatoid arthritis psoriasis cutaneous peripheral tcell development drug ultimately discontinued termination immune activation dostarlimab ibalizumab monoclonal article stub help wikipedia expanding antineoplastic immunomodulatory drug article stub help wikipedia expanding httpsenwikipediaorgwikizanolimumab